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meet eligibility criteria when compared with their Caucasian counterparts. These 
identified shortcomings related to MTM delivery within the Part D population 
remain unresolved. In order to target beneficiaries that will benefit most from 
MTM services, and ensure optimal outcomes in all MTM delivery settings, our 
recommendations to CMS are as follows: CMS should incorporate medication 
adherence measures into annual MTM eligibility criteria; CMS should require 
that plan sponsors adhere to the industry standard of including at least 25% of 
their total Part D population in MTM programs; CMS should include MTM out-
comes data in the determination of health plan star ratings and reimburse-
ment structures; and CMS should require health plans and affiliated healthcare 
organizations to grant MTM providers access to patients’ electronic medical 
records.
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BAckground: The coverage and payment level of China basic medical insurance 
grew rapidly during the healthcare reform. Those growth leads huge pressure to 
the financing mechanism. How to well allocate limited budget is a challenge. Thus 
the government started to buy commercial health insurance for some critical dis-
eases for people since 2012. In 2014, the State Council further published 2 notifica-
tions to encourage commercial insurance agencies to take more responsibility in 
healthcare. Method: This article searched and reviewed the studies for the medical 
insurance system of China, US (the country with the largest commercial insurance 
system) and UK (typical universal welfare country), then compared social environ-
ment (population, age structure and etc.), economic status, government structure 
and medical insurance system among the 3 countries, to discuss the possibility 
that commercial health insurance can solve the challenge in the reform. results 
And discussion: Those factors compared are different and decide that commer-
cial health insurance will play different role. Although China government wish to 
provide universal basic medical insurance like UK, while the limited inputs pushed 
the government have to consider US mode. The policies from the State Council 
in 2014 encouraged commercial insurance agencies “comprehensive interfere in 
the management of medical insurance”, and “give more preference to commercial 
insurance”. However commercial health insurance is hard to relieve the financial 
pressure in the reform: 1. Currently commercial insurance agencies are only allowed 
to interfere in critical diseases and will face high risk (and potential loss); 2. The 
government only allow state-owned agencies to participate, hence government 
still needs to pay the bill for the potential loss; 3. Unlike US, all Chinese residents 
should participate basic medical insurance, and the financial pressure will continue 
to increase due to aging population.
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A patient registry is defined, by Gliklich and Dreyer, as “an organized system that 
uses observational study methods to collect uniform data (clinical and other) to 
evaluate specified outcomes for a population defined by a particular disease, con-
dition or exposure, and that serves one or more predetermined scientific, clinical, 
or policy purposes”. In a vast country like India it is important to have patient 
registries in order to understand epidemiology and plan healthcare programs 
effectively in order to reduce morbidity and mortality, and develop a long term 
strategy to provide appropriate care to patients. First such registry was started 
in India by Indian Council of Medical Research (ICMR) in December 1981, which 
was a network of cancer registries across the country. This program was termed 
National Cancer Registry Program (NCRP). The objectives of the NCRP were to 
generate reliable data on magnitude and patterns of cancer, undertake epide-
miological studies, provide strategies for National Cancer Control Program and 
Develop human resource in cancer registration and epidemiology. The data for 
NCRP is collected through hospital based cancer registry and population based 
cancer registry. The NCRP has generated invaluable human resources in cancer 
epidemiology and registration. The registry has provided high level data on cancer 
occurrence, which is used for National Cancer Control Program (NCCP). However, 
the notification of cancer cases by public and private hospitals, for NCRP, is not 
mandatory. This might lead to possibility of many cancer cases go unnoticed. A 
mechanism to have nodal agencies to collect and collate data from public and 
private hospitals as well as private nursing homes, through legislation mandating 
compulsory reporting of cancer cases might provide much more useful informa-
tion on epidemiology, morbidity and mortality cases along with future direction 
for designing intervention strategies.
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Healthcare spending has been keeping on rising faster than national gross domestic 
product. The public healthcare expenditure can be associated with two major key 
categories: demographic and economic drivers. The increase of healthcare budget 
in response to growing demand without its assessment and governance is no longer 
a valuable option. Health data are essential because their analyses give the chance 
to allow a better comprehension of health events experienced in patients’ real life. 
Moreover, it is worth noting that health data are also extremely important as a 
compelling tool in evaluation and advancement of health governance. In spite of its 
magnitude in the overall economy, the tangled key elements that drive healthcare 
expenditure have been rarely recognised, measured and comprehended. To tackle 
the healthcare spending growth, it may be useful to design and implement an effec-
tive, advanced system to generate and analyse real and qualified health data. To 
this purpose, the methodological approach given by the Health Data Entanglement 
is a particularly suitable option. Entanglement concept is borrowed from quantum 
physics and means that multiple particles (or information) are linked together in 
a way such that the measurement of one particle’s quantum state (in our context, 
individual health conditions and related economic requirements) determines the 
possible quantum states of other particles (i.e. population health forecasts to pre-
dict their overall impact and support policy decisions). The value created by the 
Health Data Entanglement is based on wider and combined evaluation of clinical, 
economic and social effects generated by health interventions. Subsequent analyses 
of data can be performed using the self-learning artificial intelligence, in which 
sequential decisions are based on Bayesian algorithmic probabilities. Health Data 
Entanglement and artificial intelligence-based analyses can be adopted to improve 
the effectiveness of health governance system in ways that also lead to better qual-
ity of care.
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oBjectives: National Health Insurance of Taiwan has offered every citizen equal 
access to health services and financial risk protection from medical expenses. In 
addition, purchasing private insurances is still popular. The average contracts owned 
per person is 2.23 in 2012 and has increased to 2.30 in 2013. The premium cost of 
the National Health Insurance of Taiwan is not a user charged policy, but rather 
an income-based formula, and most insurances including the National Health 
Insurance is powered by workforces from the younger cohort. We want to esti-
mate the value of insurance policies by adding the population structure factor. This 
will reveal the impact to the average value as the population changes. Methods: 
We have added the population module into our FinancialCloud system. Data are 
acquired from Taiwan government open data and dynamic information, i.e., interest 
rate and foreign exchange rates, are update daily. By computing every possible out-
put of insurance policies for each age cohort (in 5-years interval, e.g. 0-4, 5-10, and 
so on), we can derive the expected value of a policy. A single year, single term policy 
pricing may require more than 50 thousand evaluations. For multiple years, terms, 
and policies, our FinancialCloud is especially suitable for massive, distributed, and 
parallel computations. results: Considering a single cohort over the total popu-
lation can cause price differences of more than 2%, and can even be greater if the 
term length and population structure changes. For 10 years term, approximately 60% 
younger cohort is supporting the 40% older cohort, and changes to 68%/32% in 20 
years estimate. conclusions: For different cohort, the value of a same insurance 
policy can be different. This factor must be considered to get a better estimate of the 
policy’s expected value. Rebalancing the premium fee for insurances is necessary if 
the population structure changes.
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oBjectives: Uterine fibroids (UF) affect more than one-fifth of US reproductive age 
women. While multiple medical therapies are available, there are little data on how 
long patients stay on a medical therapy before they switch to other medications or 
procedural treatment. Identifying successful and lasting medical therapies would 
better inform patients and providers, and reduce the number of hysterectomies. This 
study compares four medication classes (short-acting reversible contraceptive ster-
oids (SARC), long-acting reversible contraceptive steroids (LARC), leuprolide acetate 
(LA) and tranexamic acid (TA) for controlling heavy menstrual bleeding (HMB) in UF 
patients. Methods: Using a large private health insurance claims database (Optum 
Labs Data Warehouse), we identified women aged 18-54 with UF and HMB diagnoses 
and medical therapy between 2000 and 2013. We defined patients’ first medica-
tion after diagnosis as the index medication (and the study drug cohorts), and 
assessed the duration of their index medical therapy and whether they switched. 
Propensity score matching and survival analysis were used to compare different 
medications. results: Of the 41,561 eligible women, the four drug cohorts had 
33,000 (79.4%: SARC), 3,928 (9.5%: LARC), 3,525 (8.5%: LA), and 1,108 (2.7%: TA), respec-
tively. 16,594 (40.0%) switched to non-index medication or procedural treatment. 
Among the patients who switched, 45.7% switched to hysterectomy, 24.1% switched 
to endometrial ablation, 8.5% switched to myomectomy, and 18.4% switched to 
another medication class. Patients on LARC were much less likely to switch in the 
short term (e.g., within 60 days), but the effect was similar to SARC in the long term 
(on average HR= 0.63, p< 0.001). Patients on leuprolide acetate (HR= 2.41, p< 0.001) 
and tranexamic acid (HR= 1.49, p< 0.001) were more likely to switch, compared to 
those on SARC. conclusions: When treating HMB related to UF, women are more 
likely to stay on medications that have contraceptive benefits (i.e., LARC and SARC), 
compared to leuprolide acetate and tranexamic acid.
